Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

Authors

  • Tawee Tanvetyanon M.D.

    1. Division of Hematology/Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois
    2. Edward Hines Jr. Veteran Administration Hospital, Hines, Illinois
    Search for more papers by this author

No abstract is available for this article.

Ancillary